Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (141-150 of 509) with videos related to

Pageof 51
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 17, 2022
Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIVReja E A Schaaf, Myrthe L Verburgh, Anders Boyd, et al.
The New England Journal of Medicine|June 17, 2005
Triple HIV-1 infectionAntoinette C van der Kuyl, Karolina Kozaczynska, Remco van den Burg, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2006
The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicityMark A Boyd, Umaporn Siangphoe, Kiat Ruxrungtham, et al.
AIDS Care|March 23, 2013
Antiretroviral therapy drug adherence in Rwanda: perspectives from patients and healthcare workers using a mixed-methods approachJoseph Vyankandondera, Kirstin Mitchell, Brenda Asiimwe-Kateera, et al.
Antiviral Therapy|November 30, 2005
Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapyAlessandro Cozzi-Lepri, Lidia Ruiz, Clive Loveday, et al.
Nanomaterials (Basel, Switzerland)|July 2, 2020
Hydrothermal Synthesis of Aqueous-Soluble Copper Indium Sulfide Nanocrystals and Their Use in Quantum Dot Sensitized Solar CellsCalink I L Santos, Wagner S Machado, Karl David Wegner, et al.
HIV Clinical Trials|October 25, 2007
Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES)Selwyn H Lowe, Elly A M Hassink, Berthe L F van Eck-Smit, et al.
The Lancet. HIV|January 15, 2016
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Annals of Internal Medicine|August 21, 2002
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapyOle Kirk, Peter Reiss, Caterina Uberti-Foppa, et al.
BMC Medicine|May 13, 2021
Association between HIV infection and hypertension: a global systematic review and meta-analysis of cross-sectional studiesKatherine Davis, Pablo Perez-Guzman, Annika Hoyer, et al.
Pageof 51

Showing results (141-150 of 509) with videos related to

Sort By:
Pageof 51
Journal of Acquired Immune Deficiency Syndromes (1999)|October 17, 2022
Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIVReja E A Schaaf, Myrthe L Verburgh, Anders Boyd, et al.
The New England Journal of Medicine|June 17, 2005
Triple HIV-1 infectionAntoinette C van der Kuyl, Karolina Kozaczynska, Remco van den Burg, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2006
The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicityMark A Boyd, Umaporn Siangphoe, Kiat Ruxrungtham, et al.
AIDS Care|March 23, 2013
Antiretroviral therapy drug adherence in Rwanda: perspectives from patients and healthcare workers using a mixed-methods approachJoseph Vyankandondera, Kirstin Mitchell, Brenda Asiimwe-Kateera, et al.
Antiviral Therapy|November 30, 2005
Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapyAlessandro Cozzi-Lepri, Lidia Ruiz, Clive Loveday, et al.
Nanomaterials (Basel, Switzerland)|July 2, 2020
Hydrothermal Synthesis of Aqueous-Soluble Copper Indium Sulfide Nanocrystals and Their Use in Quantum Dot Sensitized Solar CellsCalink I L Santos, Wagner S Machado, Karl David Wegner, et al.
HIV Clinical Trials|October 25, 2007
Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES)Selwyn H Lowe, Elly A M Hassink, Berthe L F van Eck-Smit, et al.
The Lancet. HIV|January 15, 2016
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Annals of Internal Medicine|August 21, 2002
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapyOle Kirk, Peter Reiss, Caterina Uberti-Foppa, et al.
BMC Medicine|May 13, 2021
Association between HIV infection and hypertension: a global systematic review and meta-analysis of cross-sectional studiesKatherine Davis, Pablo Perez-Guzman, Annika Hoyer, et al.
Pageof 51